World Health Organization et al., 2017: WHO's 2017 guideline publication page for the alternative (including three-drug) MDA regimens against lymphatic filariasis, with its four annexes including GRADE tables and a declaration-of-interests table.
This guideline serves as a response to countries that have requested WHO to devise alternative regimens to realign their national programmes towards elimination by 2020.
World Health Organization et al., 2017: WHO's 2017 guideline publication page for the alternative (including three-drug) MDA regimens against lymphatic filariasis, with its four annexes including GRADE tables and a declaration-of-interests table. Document number WHO/HTM/NTD/PCT/2017.07. Opened the WHO publication landing page; the full 50-page PDF would not load from iris.who.int (DSpace JavaScript shell) and the NCBI Bookshelf mirror returned a CAPTCHA, so the excerpt is from the page's own overview text, not the recommendation chapter , hence MEDIUM. Product identity: WHO/HTM/NTD/PCT/2017.07, ISBN 978 92 4 155016 1, 50 pages. Annex 4 is a declaration-of-interests table for the guideline development group. The recommendation itself (single-dose IDA, with the caveat that it should not be used where onchocerciasis or loiasis is co-endemic) is quoted in IVE-04 from the current fact sheet. Study type: regulatory record.
